Sfoglia per AUTORE
GALLI M
Collezione ASL Vercelli

  

Items : 8

Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials. in Haematologica / Haematologica. 2025 Apr 1;110(4):1028-1033. doi: 10.3324/haematol.2024.286658. Epub 2024 Nov 28.

2025
ASL Vercelli
AOU Città della Salute di Torino
AOU Novara

Morabito F; Musto P; Di Raimondo F; Petrucci MT; Neri A; Coscia M; Galli M; De Stefano V; Amico V; Di Renzo N; Quinto AM; Brunori M; Cotzia E; Pietrantuono G; Montefusco V; Gozzetti A; Neri S; Monachesi M; Maggi A; Zambello R; Lombardo A; Citro A; Uccello G; Roccotelli D; Amendola A; Califano C; Morè S; Rivolti E; Nappi D; et alii...

Acute cerebellitis in children: An eleven year retrospective multicentric study in Italy in Italian Journal of Pediatrics

2017
ASL Vercelli

Lancella L; Esposito S; Galli ML; Bozzola E; Labalestra V; Boccuzzi E; Krzysztofiak A; Cursi L; Gattinara GC; Mirante N; Buonsenso D; Tagliabue C; Castellazzi L; Montagnani C; Tersigni C; Valentini P; Capozza M; Pata D; Di Gangi M; Dones P; Garazzino S; Baroero L; Verrotti A; Melzi ML; Sacco M; Germano M; Greco F; Uga E; Crichiutti G; et alii...

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. in Blood / Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.

2013
AOU Città della Salute di Torino
ASL Vercelli

Larocca A; Montefusco V; Bringhen S; Rossi D; Crippa C; Mina R; Galli M; Marcatti M; La Verde G; Giuliani N; Magarotto V; Guglielmelli T; Rota-Scalabrini D; Omedé P; Santagostino A; Baldi I; Carella AM; Boccadoro M; Corradini P; Palumbo A;

Salvage treatment with pomalidomide-cyclophosphamideprednisone produces similar outcomes as compared to prior therapies in patients with relapsed/refractory multiple myeloma in Haematologica

2013
ASL Vercelli

Larocca A; Montefusco V; Oliva S; Spriano M; Santagostino A; Genuardi M; Rota-Scalabrini D; Guglielmelli T; Giuliani N; Moscetti A; Mina R; Marcatti M; Galli M; Gilestro M; Crippa C; Baldi I; Rossi D; Boccadoro M; Corradini P; Palumbo A;

Pomalidomide cyclophosphamide and prednisone is active in lenalidomide relapsed/ refractory multiple myeloma in Clinical Lymphoma, Myeloma and Leukemia

2013
ASL Vercelli

Larocca A; Montefusco V; Oliva S; Rossi D; Crippa C; Genuardi M; Galli M; Marcatti M; Moscetti A; Giuliani N; Mina R; Guglielmelli T; Rota-Scalabrini D; Oddolo D; Santagostino A; Baldi I; Spriano M; Boccadoro M; Corradini P; Palumbo A;

Pomalidomide cyclophosphamide and prednisone (PCP) treatment for relapsed/refractory multiple myeloma in Blood

2012
ASL Vercelli

Palumbo A; Larocca A; Montefusco V; Rossi D; Carella AM; Mina R; Crippa C; Sciacca M; Galli M; Scalabrini DR; Marcatti M; Guglielmelli T; Giuliani N; La Verde G; Baldi I; Muccio VE; Boccadoro M; Corradini P;

High response rates to pomalidomide-cyclophosphamideprednisone (PCP) in patients with multiple myeloma relapsed/refractory to lenalidomide: Results of a phase I/II study in Haematologica

2012
ASL Vercelli

Palumbo A; Larocca A; Lupo B; Montefusco V; Rossi D; Carella A; Crippa C; Santagostino A; Galli M; Rota Scalabrini D; Marcatti M; Guglielmelli T; Giuliani N; Laverde G; Magarotto V; Saraci E; Baldi I; Boccadoro M; Corradini P;

A phase I/II study of pomalidomide-cyclophosphamide-prednisone (PCP) in patients with multiple myeloma relapsed/refractory to lenalidomide in Blood

2011
ASL Vercelli

Palumbo A; Larocca A; Carella AM; Rossi D; Montefusco V; Ferrari S; Santagostino A; Guglielmelli T; Galli M; Capaldi A; Giuliani N; Verde GL; Omedè P; Baldi I; Boccadoro M; Corradini P;